Arcutis Biotherapeutics announces promotions on executive management team

Arcutis Biotherapeutics (ARQT) announced several promotions to support further growth of Arcutis and the ZORYVE portfolio. Patrick Burnett, MD, PhD, FAAD, chief medical officer, has been promoted to executive vice president, chief medical officer. Dr. Burnett joined Arcutis in August 2020 and has led the advancement of the Arcutis pipeline and scientific evidence generation. L. Todd Edwards, chief commercial officer, has been promoted to executive vice president, chief commercial officer. Kent Taylor has been promoted to senior vice president of sales, having joined Arcutis in late November of 2023 as vice president of sales.